Turkish Version of the Headache Screening Questionnaire

This multi-center, nationwide study aims to evaluate the validity and reliability of the Turkish version of the Headache Screening Questionnaire (HSQ-TR). The 10-item questionnaire is designed to screen for migraine and tension-type headache in individuals with headache complaints.

Participants presenting with headache will be enrolled. Each participant will first complete the HSQ-TR and then be examined by a neurologist who will provide a diagnosis according to the ICHD-3 beta criteria. The questionnaire results will be compared with the neurologist's diagnoses to assess criterion validity, including sensitivity, specificity, and agreement.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Migraine Brain Diseases Central Nervous System Diseases Headache Headache Disorders Headache Disorders, Primary Migraine Disorders Nervous System Diseases Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms Tension Type Headache Tension-Type Headache

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Individuals aged 18 and over who present with headache complaints (migraine or tension-type) and voluntarily agree to participate

Exclusion criteria

Individuals with severe psychiatric disorders, illiteracy in Turkish, or significant cognitive impairment preventing comprehension of the scale

Treatment and study plan

Headache Screening Questionare

Diagnostic Test

The Headache Screening Questionnaire (HSQ) is a 10-item tool developed to screen for migraine and tension-type headache (TTH), based on the ICHD-3 beta criteria.

Each item reflects a diagnostic criterion for migraine or TTH. Participants complete the HSQ and are also evaluated by a neurologist for diagnosis.

A score of 6 or higher suggests "probable migraine" or "probable TTH."

Primary outcomes

ICHD-3 Beta Classification

Time frame: Day 1, Two weeks later control
Headache Screening Questionare

Time frame: Day 1,Two weeks later control

Study contacts

Contact information is provided by the study sponsor or research team.

Gizem Gürsoy, Medical Doctor

CONTACT

[email protected]

02166321818

Sponsors and collaborators

Lead sponsor

Başakşehir Çam & Sakura City Hospital

Other Gov

Collaborators

Umraniye Education and Research Hospital

Registry information

Official study title

Validity and Reliability of the Turkish Version of the Headache Screening Questionnaire

Important dates

Study start: 2025
Primary completion: 2025
Study completion: 2025
First posted: Jul 2, 2025
Registry last updated: Jul 15, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting